CN Stock MarketDetailed Quotes

301333 R&G PharmaStudies

Watchlist
  • 45.12
  • -2.26-4.77%
Trading Jan 8 11:26 CST
4.36BMarket Cap35.98P/E (TTM)

R&G PharmaStudies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

R&G PharmaStudies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 981.518M--
--2024/FY-- / 811.307M--
--2023/FY721.373M / 770.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 981.518M--
--2024/FY-- / 811.307M--
--2023/FY721.373M / 770.000M--
--------
--------

Unlock Free Earnings Estimates

R&G PharmaStudies Earnings Reports

  • Norsk: Third quarter 2024 report

    Oct 29, 2024 12:00 ET

  • Norsk: 2024 Semi-Annual Report

    Aug 28, 2024 12:00 ET

  • Norsk: 2024 Semi-Annual Report Summary

    Aug 28, 2024 12:00 ET

  • Norske: Annual Report 2023

    Apr 21, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    HUAWEI DESIGN
    833427
    13.24 +20.36%
    Shanghai Kaytune Industrial
    301001
    36.84 +20.00%
    Ji Yao Holding Group
    300108
    1.14 +20.00%
    Zhengzhou Tiamaes Technology
    300807
    43.64 +19.99%
    Jiangsu Canlon Building Materials
    300715
    9.74 +19.95%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 7, 2025

    Strong Buy

    • Strong Buy

      63.64%

    • Buy

      36.36%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Finance and Securities Lending
    Finance and Securities Lending
    Intraday-1.49%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday-1.49%
    Innovative Drugs
    Innovative Drugs
    Intraday-2.14%